Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
ONO PHARMA, Apr-Jun (1Q) Net Income Decreases by 29%
Consolidated Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2026 (IFRS)
Notice concerning the Establishment of Ono Global Reinsurance, Inc. as an Overseas Subsidiary (Specified Subsidiary)
Notice on Completion of Disposal of Treasury Shares as Tenure-based Restricted Stock Compensation and Performance-linked Restricted Stock Compensation
[Delayed]Corporate Governance Report
Notice of Disposal of Treasury Shares as Tenure-based Restricted Stock Compensation and Performance-linked Restricted Stock Compensation
ONO PHARMA, 34% Increase in Net Income for The Current Fiscal Year
Consolidated Financial Results for the Fiscal Year Ended March 31, 2025 (IFRS)
Fiscal Year 2024 (April 1, 2024 to March 31, 2025) Supplementary Materials (Consolidated IFRS)
Notice regarding Differences in the Non-consolidated Financial Results between the Fiscal Year Ended March 31, 2025 and the Previous Fiscal Year
ONO PHARMA, Last Fiscal Year Net Income Revised Downward by 14%
Revisions of Consolidated Financial Forecasts
Changes of the Board of Directors and Corporate Officers
Corporate Governance Report
ONO PHARMA, Apr-Dec (Cumulative 3Q) Net Income Decreases by 49%, Oct-Dec Net Income Decreases by 59%
ONO PHARMACEUTICAL CO., LTD., The Current Fiscal Year Net Income Revised Downward by 36%